GlassScriptPhysician profile
Paul John Addamo, JR.
NPI 1346730611
$2,243.98
in general payments reported to CMS, 2019-2025
8 companies · $1,859 in 2025
The $1,859 reported for 2025 was more than what 91% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $52.10 · 2024: $332 · 2025: $1,859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,243.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,116.58 | 2024-2025 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Connector |
| Kls-Martin L.P. | $345.24 | 2025 | |
| Acera Surgical, INC. | $270.09 | 2024-2025 | Restrata Wound Matrix |
| Stryker Corporation | $244.23 | 2023-2025 | Vsp System, Vsp Cranial, Na, Smartlock |
| Kerecis Limited | $212.43 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $25.40 | 2024 | Na |
| Solventum Corporation | $15.51 | 2025 | 3m Espe Filtek Supreme Ultra Universal Restorative, Filtek, Clinpro |
| Dentsply Sirona INC | $14.50 | 2024 | Suresmile |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Addamo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.